Hallux Valgus (Bunion) - Epidemiology Forecast to 2030

‘Hallux Valgus (Bunion) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Hallux Valgus (Bunion) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Hallux Valgus (Bunion) Understanding
Hallux valgus, commonly known as a Bunion, is one of the most common progressive forefoot deformities across the globe. A bunion is basically a “bump” which develops at the joint of the big toe—the metatarsophalangeal (MTP) joint. The big toe is made up of two joints. The larger of the two is the MTP, where the first long bone of the foot (metatarsal) meets the first bone of the toe (phalanx). Bump formation happens slowly over long period of time and finally progresses when the bone or tissue at the big toe joint moves out of alignment. Many women wear tight, narrow shoes that squeeze the toes together, creating favorable conditions for a bunion to develop, deteriorate, and cause painful symptoms. Apart from wearing tight-narrow shoes, heredity and other inflammatory condition, such as rheumatoid arthritis or a neuromuscular condition, such as polio, cause bunion in an individual. Clinically, bunions are classified into three types, mild, moderate, and severe. Hallux valgus severity can be defined as the angulation of the big toe at the first metatarsophalangeal joint and classified as mild (20°–30°), moderate (30°–40°) and severe (>40°). Bunions can occur in any gender or age group, but they are most commonly observed in women and the elderly.

Epidemiology Perspective
The Hallux Valgus (Bunion) epidemiology division provides insights about historical and current patient pool and forecasted trends for each seven major countries. The Hallux Valgus epidemiology data are studied through Hallux Valgus possible division to give a better understanding of the Disease scenario in the 7MM.
The disease epidemiology covered in the report provides historical as well as forecasted Hallux Valgus (Bunion) epidemiology [segmented as Total Prevalent Cases of Hallux Valgus (by Age), Total Diagnosed Prevalent Cases of Hallux Valgus, Severity-specific Prevalent Cases of Hallux Valgus, Severity-specific Prevalent Cases of Hallux Valgus, Treated cases of Hallux Valgus] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2030.

Hallux Valgus (Bunion) Detailed Epidemiology Segmentation
• In the year 2017, the total prevalent cases of Hallux Valgus were 172,039,751 in the 7MM. In the 7MM, among all the age groups 11,973,464 cases were accounted for less than 18 years, whereas for the age group 18–65 years and more than 65 years accounted for 109,690,287 and 50,376,000 number of cases for the year 2017.
• The United States, in 2017, accounted for 70,259,180 cases (the highest number among the 7MM countries).
• Among the EU-5 countries, the highest number of cases of Hallux Valgus were in Germany, i.e., 18,748,873 cases in the year 2017, which is estimated to rise by the year 2030.
• In the 7MM, in 2017 diagnosed Hallux Valgus prevalent cases accounted for 137,631,801 in 2017.
• The risk of hallux valgus is 2 to 3-fold higher in females compared to males. In the 7MM, the total gender-specific prevalent cases of Hallux Valgus was 41,609,614 for males and 96,022,186 for females in the year 2017
• Among the 7MM, Japan accounted for 28,351,056, prevalent cases in 2017.
• In the 7MM, 91,249,883 mild Hallux Valgus cases were observed in 2017. For moderate and severe Hallux Valgus type, 37,435,850 and 8,946,067 number of cases were observed in 2017, respectively.

Scope of the Report
• The Hallux Valgus report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• The Hallux Valgus Report and Model provide an overview of the risk factors and global trends of Hallux Valgus in the seven major markets (7MM: United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan).
• The report provides insight about the historical and forecasted patient pool of Hallux Valgus in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Hallux Valgus .
• The report provides the segmentation of the Hallux Valgus epidemiology by Total Prevalent Cases of Hallux Valgus (by Age) in the 7MM.
• The report provides the segmentation of the Hallux Valgus epidemiology by Total Diagnosed Prevalent Cases in the 7MM.
• The report provides the segmentation of the Hallux Valgus epidemiology by Gender-specific Prevalent Cases of Hallux Valgus in the 7MM.
• The report provides the segmentation of the Hallux Valgus epidemiology by Severity-specific Prevalent Cases of Hallux Valgus in the 7MM.
• The report provides the segmentation of the Hallux Valgus epidemiology by Treated Cases of Hallux Valgus in the 7MM.

Report Highlights

• 11-Year Forecast Of Hallux Valgus Epidemiology
• 7MM Coverage
• Total Prevalent Cases of Hallux Valgus (by Age) in the 7MM
• Total Diagnosed Prevalent Cases of Hallux Valgus in the 7MM.
• Gender-specific Prevalent Cases of Hallux Valgus in the 7MM.
• Severity-specific Prevalent Cases of Hallux Valgus in the 7MM.
• Treated cases of Hallux Valgus in the 7MM.
KOL-Views
We interview, KOL’s and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the over Hallux Valgus scenario of the indications.

Key Questions Answered
• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hallux Valgus?
• What are the key findings pertaining to the Hallux Valgus epidemiology across the 7MM and which country will have the highest number of patients during the study period (2017–2030)?
• What would be the total number of patients of Hallux Valgus across the 7MM during the study period (2017–2030)?
• Among the EU5 countries, which country will have the highest number of patients during the study period (2017–2030)?
• At what CAGR the patient population is expected to grow in the 7MM during the study period (2017–2030)?
• What are the various recent and upcoming events which are expected to improve the diagnosis of Hallux Valgus?

Reasons to buy
The Hallux Valgus Epidemiology report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the global Hallux Valgus market
• Quantify patient populations in the global Hallux Valgus market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Hallux Valgus therapeutics in each of the markets covered
• Understand the magnitude of Hallux Valgus population by its severity
• The Hallux Valgus epidemiology report and model were written and developed by Masters and PhD level epidemiologists
• The Hallux Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Study Period: 2017–2030